Cargando…
Proteasomal and lysosomal degradation for specific and durable suppression of immunotherapeutic targets
Cancer immunotherapy harness the body’s immune system to eliminate cancer, by using a broad panel of soluble and membrane proteins as therapeutic targets. Immunosuppression signaling mediated by ligand-receptor interaction may be blocked by monoclonal antibodies, but because of repopulation of the m...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Compuscript
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476092/ https://www.ncbi.nlm.nih.gov/pubmed/32944392 http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0066 |